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Abstract
SUMO is a protein modifier that is vital for multicellular development. Here we present the first system-wide analysis,
combining multiple approaches, to correlate the sumoylated proteome (SUMO-ome) in a multicellular organism with the
developmental roles of SUMO. Using mass-spectrometry-based protein identification, we found over 140 largely novel
SUMO conjugates in the early Drosophila embryo. Enriched functional groups include proteins involved in Ras signaling, cell
cycle, and pattern formation. In support of the functional significance of these findings, sumo germline clone embryos
exhibited phenotypes indicative of defects in these same three processes. Our cell culture and immunolocalization studies
further substantiate roles for SUMO in Ras signaling and cell cycle regulation. For example, we found that SUMO is required
for efficient Ras-mediated MAP kinase activation upstream or at the level of Ras activation. We further found that SUMO is
dynamically localized during mitosis to the condensed chromosomes, and later also to the midbody. Polo kinase, a SUMO
substrate found in our screen, partially colocalizes with SUMO at both sites. These studies show that SUMO coordinates
multiple regulatory processes during oogenesis and early embryogenesis. In addition, our database of sumoylated proteins
provides a valuable resource for those studying the roles of SUMO in development.
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Introduction
Post-translational protein modification adds layers of complexity
to macromolecular function. One way of modifying proteins is by
joining the ubiquitin family proteins to lysine residues, generating
branched proteins [1]. One such ubiquitin-like protein, SUMO
(small ubiquitin-related modifier), displays remarkable versatility in
modulating target protein function. Many proteins are targeted for
covalent modification by SUMO, which consequently modulates
many cellular processes [2–4].
Genetic analysis has revealed essential roles for SUMO in the
survival and development of organisms ranging in complexity from
yeast to mammals [2–4]. In S. cerevisiae, mutations in genes encoding
SUMO pathway enzymes are lethal [5–7], while mutations in the
corresponding genes in S. pombe severely impair growth [8–10].
Deletion of genes encoding enzymes required for SUMO
conjugation in C. elegans leads to embryonic lethality [11], while
reduction of the SUMO conjugating enzyme levels in Drosophila,
zebrafish, and mouse results in developmental defects [12–14].
The Drosophila melanogaster genome encodes a single form of
SUMO (herein referred to as Drosophila SUMO, but also known as
Drosophila Smt3), which shares 52% and 73% sequence identity
with human SUMO-1 and SUMO-2, respectively [15]. Drosophila
and human SUMO family proteins are at least partially
interchangeable, demonstrating a high level of SUMO pathway
conservation between evolutionarily distant organisms [16]. To
date, only a few Drosophila proteins, such as the transcription
factors Dorsal [17,18], Tramtrack [16], Vestigial [19], SoxNeuro
[20], and Medea [21]; the gypsy insulator interacting proteins
Mod(mdg4) and CP190 [22]; as well as the bi-functional tRNA
charging enzyme glutamylprolyl-tRNA synthetase (EPRS, [23])
are known to be sumoylated. SUMO appears to have diverse roles
in the Drosophila life cycle, including the regulation of transcription
and the modulation of the immune response [18,20].
While SUMO is present throughout development, early Drosophila
embryos contain particularly high concentrations of maternally
contributed SUMO and the enzymes required for SUMO
conjugation [16,24,25], suggesting that sumoylation may play
particularly critical roles at this stage of fly development. Previous
global analyses of SUMO substrates in S. cerevisiae and mammalian
cultured cells have produced extensive lists of novel sumoylation
targets [26–35]. To date, however, there are no published studies that
document the spectrum of sumoylated proteins in a specific
developmental setting in a multicellular organism.
To broaden our understanding of the function of sumoylation in
early Drosophila development, we performed a mass spectrometry-
based global identification of sumoylation targets in early embryos,
and found over 140 direct sumoylation targets. Among the
identified SUMO target proteins are players in many processes
essential to embryonic development, including proteins involved in
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determine the functional significance of the identified sumoylated
proteins, we carried out genetic, cell culture and immunolocali-
zation studies, obtaining evidence for roles of SUMO in these
same three processes. Thus, the proteomic, genetic, and cellular
studies presented here all converge to suggest that SUMO
coordinates key aspects of early metazoan development.
Results
Isolation, identification, and categorization of early
embryonic SUMO conjugates
To determine the early embryonic SUMO-ome (catalog of
sumoylated proteins), we adopted a scheme that involved a two-
step affinity purification strategy using SUMO tagged at its N-
terminus with both (His)6 and FLAG tags, followed by liquid
chromatography-tandem mass spectrometry (LC-MS/MS)-based
protein identification of trypsin-digested proteins (Figure 1A). We
initially attempted to express tagged SUMO using modified sumo
genomic clones, but were unsuccessful presumably due to the need
for unknown distant cis-regulatory modules to direct sumo
expression. We therefore turned to the Gal4-UAS system [36],
and drove ubiquitous maternal expression of tagged SUMO at
levels slightly lower than that of endogenous SUMO (Figure S1).
Tagged SUMO rescues the lethality resulting from sumo mutations
(data not shown) demonstrating the functionality of the tagged
protein.
In other organisms and cultured cells, heat shock is known to
enhance global sumoylation [34,37]. We observed a similar
phenomenon in early embryos (Figure S1). Since the SUMO
conjugates were in low abundance even when very large amount
of starting materials (five grams of fly embryos) were used, we
promoted SUMO conjugation with heat treatment at 37uC. As a
control, wild-type Oregon-R (Ore-R) embryos lacking tagged
SUMO were collected and processed under identical conditions.
While the use of heat shock could raise a concern about the
possibility of skewing the protein pool, our pilot study in which
proteins were isolated from heat-shocked and non-heat-shocked
samples revealed similar SDS-PAGE profiles (Figure S2). Further-
more, analysis by LC-MS/MS revealed a largely overlapping set
of proteins from heat-shocked and non-heat-shocked embryos
(supporting document S1 and Table S3). The observed differences
were largely quantitative rather than qualitative (Table S3)–more
peptides were identified from the majority of the proteins in the
heat-shocked than in the non-heat-shocked samples, leading to
higher confidence protein identification. Moreover, the consisten-
cy between our phenotypic analysis (see below) and our proteomic
data further increases our confidence in the biological relevance of
our SUMO-ome.
In the first step of the two-step affinity purification, the (His)6 tag
was bound to nickel-coupled agarose under strongly denaturing
conditions (containing 1% CHAPS, 8 M urea) in order to
solubilize proteins from all cellular compartments, suppress
SUMO isopeptidases, and ensure that the purified proteins are
directly conjugated to SUMO. To achieve a higher degree of
purification, second affinity chromatography step employing anti-
FLAG antibodies was carried out. Sypro Ruby staining of a gel
with proteins purified from embryos containing dual-tagged
SUMO and from negative control embryos, demonstrated very
few proteins in the control sample (Figure 1A). The SDS-PAGE
gel lanes containing the control and experimental samples were
each cut into 20 equal-size slices (Figure 1A), followed by in-gel
tryptic digestion and subsequent analysis by LC-MS/MS.
LC-MS/MS data were analyzed using Mascot (Matrix Science)
to search the database of known Drosophila protein sequences. For
proteins represented by four or fewer peptides, we manually
inspected the mass spectra to confirm the protein identifications.
SUMO tryptic peptides were detected in every gel slice from the
sample prepared from embryos expressing tagged-SUMO, and in
none of the gel slices from the sample prepared from control Ore-
R embryos. A total of 144 proteins (corresponding to 142 genes)
were uniquely found in the sample from embryos expressing
tagged-SUMO (Table S1). In addition to a large number of novel
sumoylation substrates identified, this list includes nearly all
previously validated Drosophila SUMO conjugates that are present
at this developmental stage (e.g., Dorsal, Mod(mdg4), CaMKII,
EPRS), as well as proteins that are orthologous to well-
characterized SUMO substrates found in other organisms (e.g.,
PCNA, CtBP, Topoisomerase I and II), thus adding to our
confidence in the authenticity of our SUMO-omic database.
In a separate study, tagged SUMO conjugates were isolated under
native conditions in a single-step anti-FLAG immunopurification,
and over 300 gene products were identified (Table S2). This set
includes a large fraction of the proteins (,60%) identified in the two-
step purification procedure (marked by ‘‘*’’ in Table S1). The native
purification also appears to have isolated a number of proteins that
interact with the SUMO conjugates identified in the two-step
purification carried out under denaturing conditions, as well as
proteins that were later demonstrated to be authentic SUMO
conjugation targets by independent validation methods (see below).
We used a SUMO conjugation site prediction algorithm,
SUMOsp [38], to analyze the proteins identified in the one- and
two-step purifications (Table 1). While the proteins in the entire
Drosophila proteome contain an average of 0.76 consensus SUMO
conjugation sites per protein, the proteins from the two-step
purification average 1.46 consensus sites per protein, and the
proteins from the one-step purification average 1.06 consensus sites
per protein. These differences are highly statistically significant
(Table 1). The lower number of sites in the proteins from the one-
step purification relative to the two-step purification further
supports the idea that the one-step purification yielded a mixture
of direct SUMO conjugation targets and their interacting partners.
We used the Generic Gene Ontology (GO) Term finder tool
(http://go.princeton.edu/cgi-bin/GOTermMapper) to search for
overrepresented GO categories in the SUMO substrate list when
compared to the entire fly proteome. Using the hypergeometric
distribution analysis, we calculated the probability that the
proportion of SUMO substrates mapped to a given category
could occur by random chance, given the fraction of all fly
proteins that map to that category (Table S4, S5). This analysis
helped us to distinguish several enriched functional groups of
SUMO conjugates (Table 2). We also analyzed the enrichment of
biological process GO terms in our SUMO proteome when
compared to the early Drosophila embryonic proteome (2 hr AEL
embryo [39,40]) (Table S6). Many of the same categories that are
enriched in comparison to the entire Drosophila proteome are also
significantly enriched in comparison to the early embryonic
proteome.
Inspection of the list of sumoylated proteins also suggests that
protein complexes, such as the oskar mRNP, multi-aminoacyl-tRNA
synthetase complex, a PCNA-containing protein complex, and the
ribosome, often contain multiple sumoylated proteins (Table 3).
Validation of SUMO conjugates found through global MS
analysis
Using a bacterial sumoylation assay we validated a number of
the proteins in the enriched groups as SUMO conjugation targets
SUMO in Drosophila Development
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Drosophila polypeptides essential for SUMO conjugation (SAE1,
SAE2, Ubc9, and SUMO) as well as a GST-tagged candidate
SUMO substrate. The detection of SUMO conjugates in this
system is facilitated by the lack of an absolute requirement for E3-
type ligases in sumoylation [41,42] as well as by the absence of
SUMO deconjugating enzymes in bacteria. While bacterial
sumoylation systems may not completely recapitulate the specific-
ity of sumoylation in vivo, they have been repeatedly validated as a
useful approach for confirming sumoylation targets [43–46].
Our bacterial sumoylation system includes several improve-
ments over the existing bacterial systems. We use a single vector
(Q
SUMO) to encode all four polypeptides required for sumoylation,
thereby reducing variation in expression levels. In addition, we
Figure 1. A fly SUMO-ome: characterization and validation. A) Scheme for identifying Drosophila embryonic SUMO conjugates. SUMO
conjugates were isolated by tandem affinity purification from transgenic fly embryos expressing (His)6-FLAG-SUMO. The initial purification step (Ni-
NTA chromatography) was performed under denaturing conditions. To maximize the chance of detecting low abundance proteins in the complex
protein mixture, the affinity-purified proteins were separated by SDS-PAGE, and the lane was cut into 20 evenly divided gel slices. Tryptic peptides
extracted from each gel slice were analyzed by LC-MS/MS. B) A bacterial sumoylation assay. The Q
SUMO vector, which encodes the mature form of
SUMO (SUMO
GG) along with SAE1, SAE2, and Ubc9 expressed from separate T7/lac promoters, was used in combination with a vector expressing a
GST-tagged candidate substrate. As a negative control, Q
DGG, which expresses a conjugation defective form of SUMO (SUMO
DGG), was used in place
of Q
SUMO. C) Bacterial sumoylation assays were used to validate proteins identified in the proteomic screen as sumoylation substrates. GST-tagged
candidate SUMO conjugates were expressed in BL21 cells co-transformed with Q
SUMO or Q
DGG vectors, purified using glutathione beads, and
immunoblotted using antibodies against GST, SUMO, or poly-His (to detect 6xHis-tagged SUMO). GST by itself was not sumoylated in this assay. Black
arrows point to the bands representing sumoylated proteins, and open arrow points to a non-specific reacting band. D) The eIF4E protein was
purified from Drosophila S2 cells stably expressing FLAG-(His)6- tagged eIF4E using Ni-NTA beads under denaturing conditions. The resulting proteins
were probed with anti-FLAG antibody in a Western blot. The cells were treated with SUMO or control YFP dsRNA for 3 days prior to cell lysis. In the
control sample, the bands representing the sumoylated species (black arrows) have intensities that are 8.1% (top) and 12.9% (bottom) of the intensity
of the band representing unmodified eIF4E (,40 kDa), whereas in the SUMO knockdown sample, they are reduced to 1.8% (top) and 3.5% (bottom).
Quantitation was performed using Quantity One 4.3.0 (BioRad).
doi:10.1371/journal.pone.0005905.g001
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Dataset Number of Proteins Number of Sites
* Sites per Protein Site per aa (61000) p-value
#
Two-step purification 144 210 1.46 2.17 1.48e-06
One-step purification 247 262 1.06 2.03 2.82e-04
Drosophila proteome 32182 24886 0.77 1.58 -
*Proteins from the two-step or one-step purification protocols, or total Drosophila melanogaster proteins (as annotated in the UniProtKB database) were analyzed using
the SUMOsp program to yield the total number of SUMO conjugation sites that match the canonical yKxE/D consensus motif for each dataset.
#p-values were calculated using the hypergeometric distribution to compare the number of predicted sites per amino acid in the databases of purified proteins to the
number of sites per amino acid in the Drosophila proteome.
doi:10.1371/journal.pone.0005905.t001
Table 2. Enriched functional groups of sumoylation substrates.
Cell Cycle Process
Asp, Awd
*, Cup
*, Young arrest, Hsp83
*, Polo
*{, Pumillio, Topoisomerase 2
*, Valois, Pp1-87B
*, Cdc2c
*, PP2A catalytic subunit (Microtubule star)
*{, aTub67C
*, 14-3-3 f
*,
PCNA
*{, RFC2
*{, Twinstar
*, Pitslre, Rpn2
*, Klp10A
*, Brat, (RFC1)
#
Embryonic Pattern Formation
Bicoid, Caudal, Dorsal, Hunchback, Hsp83
*, Osa, Pumillio, Retained
Maternal mRNA Regulation
Pumilio, Cup
*, Brat, Smaug, Bicoid, Tsunagi, Mago Nashi
*, Hrb27C
*, NACa, Hel25E
*, Valois, Me31b
*, (Vasa, eIF4E
{, Squid
{)
#
Ras1 signaling pathway
PP2A 65kD subunit A
*, PP2A catalytic subunit (Microtubule Star)
*{, 14-3-3 e
*, 14-3-3 f
*{,H s p 8 3
*, (PP2A regulatory subunit Twins, Ras1
{, ERK-A, Phyllopod)
#
Epigenetic regulation
Osa, Pho, Su(Var)3-7
*, Mod(mdg4), H2Av
*,N l p
*, Caf1
*, CtBP
*, (H2B, Rpd3, Groucho, Mi-2, HP1)
#
Nucleocytoplasmic transport
Exportin-1
*, Importin-a re-exporter
*, Importin b
*, Importin-a
*
*These proteins were identified through both the two-step purification and the single-step purification.
#Proteins in parenthesis were identified through the one-step purification only, and therefore may not be direct sumoylation targets. All other proteins were identified
through the two-step purification or through both the two-step purification and the single-step FLAG IP.
{These proteins were validated through the bacterial sumoylation assay as SUMO substrates are underlined. A subset of these assays is shown in Figure 1.
doi:10.1371/journal.pone.0005905.t002
Table 3. Protein complexes that include multiple sumoylation substrates.
osk mRNP
Mago Nashi
*, Tsunagi, Cup
*, Me31b
*, Hrb27C
*, NACa, Smaug, Hel25E
*, Valois, (eIF4E, squid, Vasa)
#
PCNA
PCNA
*, RFC2
*, Caf1
*, (DNApol-d, DNApol- d small subunit, RFC1)
#
tRNA Multi-Synthetase Complex (MSC)
EPRS
*, QRS
*, RRS
*, (p38)
#
Protein Phosphatase 2A (PP2A)
65kD subunit A
*, catalytic subunit Microtubule Star
*, (regulatory subunit Twins)
#
26S Proteasome
regulatory subunits: Dox-A2
*, Rpn2
*, Rpn7
*, (Rpn11)
#
Ribosome Complexes
RpS4
*, RpL8
*, RpS10b, RpL27A
*, RpS7
*, RpS3A
*, RpS16
*, RpS19
*, RpL13
*, RpL9
*, RpS3
*, RpL10Ab
*, (RpS26, RpS6, RpS10a, RpL28, RpS13, RpL13A, RpS14a, RpS20, RpL15,
RpL31, RpS15Aa, RpL7A, RpS9, RpL23, RpS17, RpL7, RpL4, RpL14, RpL18A, RpS25, RpL22, RpLP0, RpL36, RpL11, RpS8, RpL32, RpS23, RpS18, RpS5a)
#
*These proteins were identified through both two-step and one-step purification procedures.
#Proteins in parenthesis were found through the one-step purification only, and therefore may not be direct sumoylation targets.
doi:10.1371/journal.pone.0005905.t003
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vector to enable high-throughput cloning of cDNAs encoding
potential sumoylation targets. To provide a control for specificity,
we generated a control vector, Q
DGG, which encodes a
conjugation defective form of SUMO lacking the C-terminal di-
glycine motif required for SUMO conjugation [6,23].
Using this system we confirmed sumoylation of PCNA, the
processivity factor for DNA polymerase d, and RFC2 (Figure 1C),
a subunit of the factor that loads PCNA onto DNA. We also
verified sumoylation of 14-3-3 f (Figure 1C), which belongs to a
family of small proteins that interact with a multitude of
functionally diverse signaling proteins by binding to phosphory-
lated serine or threonine residues [47]. Drosophila 14-3-3 f has been
shown to function both in the Ras/MAPK pathway and in
regulation of the nuclear cleavage cycles in the syncytial embryo
[48]. Using the same assay system, we also confirmed that EPRS,
CtBP, eIF4E (Figure 1C), Squid (Figure S4B), and several other
proteins found in our MS identification (proteins underlined in
Table 2) are sumoylation substrates. We also showed that eIF4E is
sumoylated in S2 cell culture, further confirming it as a genuine
SUMO substrate (Figure 1D).
This bacterial sumoylation system does not non-specifically
sumoylate any substrate as shown by the negative controls. In
addition to GST, we also did not detect sumoylation of GFP or
HP1 (Figure S4A). This latter protein was identified in the single-
step native purification, but not through the two-step protocol that
involved initial denaturation of the extract. This suggests that HP1
interacts with sumoylated proteins, but is not itself a sumoylation
substrate. In addition, using this assay, we have been able to map
specific sumoylation sites in a number of proteins including EPRS,
Grauzone, Meics (data not shown), and Ras1 (see below).
Maternally contributed SUMO is required for embryonic
development
Among the enriched functional groups from the proteomic
screen (Table 2) are groups of proteins with functions in embryonic
pattern formation, including transcription factors, such as Dorsal,
Bicoid, and Hunchback, that guide the dorsoventral or antero-
posterior patterning of the embryo, as well as proteins involved in
the localization and translational regulation of important maternal
transcripts. We also found significant enrichment of proteins
involved in cell cycle regulation and the Ras signaling pathway. To
determine if these enriched functional groups reflect the roles of
SUMO in Drosophila embryonic development, we carried out
genetic and phenotypic analysis of flies carrying hypomorphic sumo
alleles.
Two independent P-insertions sumo alleles, termed sumo
04493 and
sumo
k01211, were subjected to phenotypic analysis. The P-insertion
in both alleles is 20 bp upstream of the transcription start site,
creating recessive lethal mutations with a lethal period before or
during the early second larval instar. Evaluation of mRNA levels
by RT-PCR in homozygous mutant larvae shows that the
sumo
04493 mutation leads to an approximately 5-fold decrease in
the level of sumo transcripts (Figure S3). Antibody staining of
mutant follicle cell clones (see below) also demonstrates a
significant reduction in SUMO levels in mutant tissue
(Figure 2A). sumo
04493, sumo
k01211, and a sumo EMS allele
(generated by Shanti Chandrashekaran, New Delhi, and obtained
through Dr. Lawrence Marsh), which contains a serine-glycine
sequence in place of the normal C-terminal di-glycine motif
required for efficient conjugation of SUMO to its targets [6,23] fail
to complement one another.
To determine the function of maternally contributed SUMO,
we created females containing homozygous sumo mutant germline
clones (GLCs) using the hsFLP/FRT dominant female sterile
method [49]. The two P-insertion alleles of sumo exhibited
overlapping spectra of defects, with the average severity of the
defects being greater in the sumo
k01211 GLC embryos (Table 4).
Since the sumo
k01211 GLC embryo-producing females laid
relatively few mature eggs, most of the subsequent phenotypic
analysis was carried out using the sumo
04493 GLC embryos.
Less than 30% of the sumo
04493 GLC embryos hatched, and all
hatched larvae died during the first larval instar. Greater than
90% of the unhatched embryos died prior to cuticle formation.
The embryos that deposited cuticle exhibited a wide range of both
anteroposterior and dorsoventral patterning defects (Figure 2B).
These defects are not rescued by zygotic SUMO expression since
embryos produced by GLC females mated with wild-type males
had similar high rates of lethality and a comparable spectrum of
defects as those embryos produced by GLC females mated with
heterozygous males. Both the patterning defects in the sumo mutant
GLC embryos and the large number of SUMO targets from our
proteomic analysis with roles in embryonic pattern formation
support the conclusion that SUMO modulates the activities of key
pattern formation gene products to help direct embryonic
development.
SUMO plays roles in eggshell patterning and potentiates
Ras/MAPK signaling
Approximately ten percent (39 out of 400) of the sumo
04493 GLC
eggs exhibited partially to fully fused dorsal appendages, indicative
of weak to moderate eggshell ventralization (Figure 2C). Drosophila
eggshell patterning is regulated by the epidermal growth factor
receptor (EGFR) signaling pathway. EGFR, a transmembrane
receptor tyrosine kinase (RTK), is found in the follicle cells where
it receives a spatially localized signal from the developing oocyte.
This signal activates the Ras signaling cascade, which patterns the
follicle cell epithelium, and is therefore essential for proper
patterning of the eggshell [50–52]. Both sumo
04493 and sumo
k01211
have been shown to enhance the weakly ventralized eggshell
phenotypes of a hypomorphic Ras1 mutant [53]. Our observation
that the sumo mutation leads to eggshell ventralization even in a
wild-type Ras1 background further supports a role for SUMO in
EGFR/Ras signaling.
Previous epistasis studies showed that reduced SUMO levels
suppressed the eggshell dorsalization resulting from a constitutively
active form of EGFR, indicating that SUMO acts downstream of
EGFR in the follicle cells [53]. Since the process of generating
GLC also leads to production of somatic clones in the follicle cells
(Figure 2A), our findings are consistent with a role for SUMO
downstream of EGFR in eggshell patterning. Intriguingly, our
proteomic analysis also found multiple proteins involved in Ras
signaling downstream of EGFR activation as potential SUMO
targets (Table 2). Further evidence that SUMO functions
downstream of EGFR is provided by experiments described
below in which we examine the effect of SUMO knockdown on
Ras signaling in S2 cells.
To determine if SUMO plays a role in Ras signaling, we
knocked down SUMO by RNAi in cultured S2R+ cells, which
express Drosophila EGFR [54], and examined the level of MAPK
activation in these cells upon activation of EGFR by the secreted
Spitz ligand, sSpi [55]. Anti-SUMO immunoblotting showed that
the treatment with SUMO dsRNA progressively decreased the
levels of both free SUMO and SUMO conjugates after 3 to 5 days
of treatment (Figure 3A). The level of Ras pathway activation was
assessed by immunoblotting for pMAPK, and all samples were
normalized by comparison to total MAPK using an antibody that
recognizes all forms of MAPK. The levels of pMAPK decreased
SUMO in Drosophila Development
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04493 GLC egg chambers. Wild-type (Ore-R;
top) and sumo
04493 GLC egg chambers (bottom) were stained with SUMO antibodies (green) and DAPI (blue). The field in the lower panels contains a
sumo
04493/04493 clone resulting from FLP/FRT recombination (yellow arrows), heterozygous sumo
04493/+ cells with a reduced level of SUMO (white
arrows), and a sumo
+/+ twin spot containing a level of SUMO comparable to that observed in Ore-R follicle cells (red arrows). B) A variety of
anteroposterior (3 panels on the left) and dorsoventral (panel on the right) patterning defects were observed in sumo
04493 mutant GLC embryos.
Among the embryos that formed cuticles, 59% (n=171) exhibited abnormal cuticular morphology. Top panel shows a wild type cuticle. C) Examples
of ventralized eggshells of sumo
04493 GLC embryos are shown in the three panels on the right. A wild type Ore-R embryo is shown in the leftmost
panel.
doi:10.1371/journal.pone.0005905.g002
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parallel treatment of cells with control YFP dsRNA had no effect
on MAPK activation (Figure 3B). SUMO RNAi similarly
impaired insulin-induced MAPK phosphorylation (Figure 3C).
Insulin or sSpi-induced MEK activation was also reduced by
SUMO knockdown (Figure 3D, normalized using the total MEK
levels). To further dissect the role of SUMO in Ras signaling, we
examined the requirement for SUMO in pathway activation by
Ras
V12, a constitutively active form of Ras1. SUMO knockdown
did not affect Ras
V12-induced MAPK activation (Figure 3E). This
suggests that SUMO knock down does not impair the processes
downstream of Ras1 activation, so SUMO pathway affects a step
upstream of Ras1 or at the level of Ras1 to activate the pathway.
Ras1 was identified in the single-step native FLAG IP of
sumoylated proteins (Table 2, Table S2), but not in the two-step
denaturing purification protocol. However, the bacterial sumoyla-
tion assay suggests that it is nonetheless a direct sumoylation
target. Sumoylated GST-Ras1 species were detected when the
functional sumoylation pathway (Q
SUMO) was co-expressed with
GST-Ras1 in E. coli (Figure 3F), and absent when conjugation
defective SUMO
DGG (Q
DGG) was employed instead (data not
shown). There is no consensus SUMO acceptor site found in the
Ras1 peptide sequence. The highest probability non-consensus
site, predicted by both SUMOsp2.0 [38] and SUMOplot
TM, is lysine
104. Mutation of lysine 104 to arginine, did not dramatically
compromise Ras1 sumoylation (Figure 3F), suggesting that Ras1
contains multiple non-consensus sumoylation sites. Functional
sumoylation on non-consensus sites, however, has been widely
observed. For example, the yeast core histones contain multiple
mass-spectrometry validated non-consensus sites that can not be
identified by any of the existing SUMO prediction programs
[56,57]. Furthermore, 26% of experimentally validated SUMO
conjugation sites are non-consensus [58]. We found that deletion
of the C-terminal 25 amino acids of Ras1 or mutations of all
lysines in this region abolished Ras sumoylation (Figure 3G),
whereas the C-terminal Ras1
165–189 peptide was sumoylated to
yield a pattern of bands in SDS-PAGE similar to that observed for
wild type Ras1 (Figure 3G), indicating that the hypervariable C-
terminal region of Ras1 contains the sites of SUMO modification.
SUMO is required for the syncytial mitotic cycles
The SUMO pathway has been shown to be required for cell
cycle progression in other organisms [59]. Consistent with this, our
proteomic analysis found proteins involved in cell cycle regulation
to be significantly over-represented among SUMO conjugates in
the early Drosophila embryo (Table 2, Table S6), and moreover our
findings significantly expands the list of know sumoylated cell cycle
regulators. To determine if the lethality caused by a reduced
maternal supply of SUMO is due to cycling defects, 0- to 3-hour
wild-type and sumo
04493 GLC embryos were stained with DAPI to
visualize DNA. During the initial stage of Drosophila embryogen-
esis, 13 nuclear cleavage cycles occur rapidly and synchronously in
a syncytium (Figure 4A). We observed that over 50% of the
sumo
04493 GLC embryos exhibited a broad spectrum of nuclear
cycle defects, including irregular size and distribution of nuclei,
asynchronous nuclear division, abnormal interphase chromosome
structure, overly condensed chromosomes, loss of sister chromatid
cohesion during metaphase, polyploidy, chromosome clustering,
fragmentation, and chromosome bridges (Figure 4B–E). Multiple
nuclear division defects were often observed in a single embryo
(Figure 4B). We also observed similar, although somewhat less
penetrant, nuclear cleavage cycle defects in embryos resulting from
GLC of a ubc9 (the SUMO conjugating enzyme) hypomorphic
allele [12], semi
118 (Figure 4F). The diverse cycling defects observed
in the sumo and ubc9 GLC embryos indicate broad involvement of
SUMO in multiple stages of the nuclear cycle, and are consistent
with our proteomic analysis showing a significant enrichment in
SUMO targets with cell cycle functions.
The mitotic cycle defects in sumo mutant GLC embryos were
further characterized through visualization of centrosomes and
microtubules. Correct spatial organization and synchronous
nuclear division of the early embryos requires a high degree of
coordination between centrosome duplication, microtubule dy-
namics, and changes in nuclear structure. Abnormalities, such as
asynchronous division, irregular nuclear spacing, and polyploidy,
observed in sumo
04493 GLC embryos, suggest an uncoupling of
these events. In wild type syncytial blastoderm embryos, each set
of chromosomes is associated with a pair of centrosomes
(Figure 5A, B). sumo
04493 embryos often contain a reduced number
of nuclei in relation to the centrosome pairs (Figure 5C), a
common mitotic defect in Drosophila [60–62].
Defects in mitotic spindle organization and attachment to
centrosomes and chromosomes were also observed in sumo GLC
embryos (Figure 5D–J). Monoastral, anastral, and multipolar
spindles, as well as unfocused broad-based spindles were
documented. These results suggest that sumoylation is important
in coordinating multiple events of mitosis, such as centrosome
replication, centrosome-spindle association, and spindle-chromo-
some attachment. The broad spectrum of mitotic defects seen in
the sumo GLC embryos is consistent with the defective mitotic
spindle assembly induced by SUMO RNAi in Drosophila S2 cells
previously observed [63], as well as with our fly SUMO-ome,
which also suggests a broad role for SUMO in mitosis.
SUMO is required for cell cycle progression in S2 cells and
larval tissue
The syncytial nuclear cleavage cycles are non-canonical mitotic
cycles lacking the gap phases as well as cytokinesis. To determine if
sumoylation is essential for cells undergoing a canonical G1-S-G2-
M cell cycle, we investigated the requirement for SUMO in cell
cycle progression of cultured cells and larval wing imaginal discs.
The DNA content of S2 cells was measured by flow cytometry to
assess cell cycle stage following three to five days of SUMO RNAi.
The fraction of G2/M phase cells gradually diminished, suggesting
G1/S arrest as a result of sustained low levels of SUMO
(Figure 6A, B).
Imaginal discs undergo rapid proliferation during larval
development. We knocked down SUMO in larval tissue by RNAi
using Gal4 to drive the expression of a sumo hairpin RNA. The
effectiveness of the RNAi was demonstrated by anti-SUMO
staining of discs containing clones of cells that express sumo hairpin
RNA (Figure S5). To examine the effects of SUMO knockdown on
the wing imaginal disc cell cycle, we employed the MS1096-Gal4
driver, which directs a high level of expression in the dorsal
compartment and a lower level of expression in the ventral
Table 4. Summary of phenotypes observed in sumo mutant
GLC embryos.
sumo
k01211 sumo
04493
Defective eggshells 30% (n=171) 10% (n=400)
Hatching rate 0% (n=171) 2360.9% (n=800)
Unhatched embryos forming cuticle 0% 10% (n=200)
Cuticles formed that appear wild-type – 41% (n=171)
doi:10.1371/journal.pone.0005905.t004
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PLoS ONE | www.plosone.org 7 June 2009 | Volume 4 | Issue 6 | e5905Figure 3. SUMO is required for Ras/MAPK signaling. In panels A to E, lysates from equal number of cells were loaded onto SDS-PAGE. A) Anti-
SUMO immunoblot of total protein from cells treated with SUMO or control YFP dsRNA. B, C) EGFR expressing S2R+ cells were treated with YFP or
SUMO dsRNA for 3 to 5 days. At the end of the RNAi treatment, 2610
6 cells were incubated in serum-free medium for one hour, then exposed to
secreted Spitz (sSpi) ligand or insulin for 7 min and immediately lysed for Western analysis. The blots were probed with antibodies against double-
phosphorylated MAPK (pMAPK) or total MAPK in B and in left half of C. In the right half of panel C, S2 cells treated with dsRNA for 5 days were
stimulated with insulin, and the same samples were probed with antibodies against a-Tubulin, pMAPK, or SUMO. D) An immunoblot of cells treated
with YFP or SUMO dsRNA, and exposed to sSpi or insulin, was probed with antibodies against phosphorylated MEK (pMEK) or total MEK. E) An
immunoblot of Ras
V12-expressing S2 cells treated with YFP or SUMO dsRNA was probed with antibodies against pMAPK or total MAPK. Ras
V12
expression was induced with copper during the last 18 hr of dsRNA treatment. F) Bacterial sumoylation of GST-Ras1 and Ras1
K104R using the
approach described in the legend to Figure 1. G) Bacterial sumoylation of GST-Ras1
1–164, Ras1
7KR, or Ras
165–189. In the lower panel (GST-Ras
165–189),
the black arrowheads point to the bands representing sumoylated proteins. Based on size, these are likely the mono-, di-, and tri-sumoylated species.
The di- and tri-sumoylated species are only visible in the anti-SUMO immunoblot as the anti-GST antibody is not sensitive enough to detect them.
The open arrowhead marks a non-specific cross-reacting band detected by the anti-GST antibody.
doi:10.1371/journal.pone.0005905.g003
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PLoS ONE | www.plosone.org 8 June 2009 | Volume 4 | Issue 6 | e5905Figure 4. sumo is required for normal syncytial nuclear cycles. A) A wild type syncytial blastoderm embryo in metaphase. B–E)
Representative nuclear cycle defects in DAPI stained sumo
04493 GLC embryos. DAPI staining revealed multiple cell cycle defects in sumo
04493 GLC
embryos. Panel B shows a sumo
04493 mutant embryo, while B9 and B0 are magnified views of two regions of the embryo in B. The arrow in B9 points
to an abnormally large cluster of chromosomes, indicating polyploidy, and the arrow in B0 points to a prominent chromosome bridge. C) Abnormal
chromosomal organization. The arrow in D highlights a possible cohesion defect. The left arrow in E points to a cluster of hypercondensed
chromosomes, and the right arrow points to chromosome fragments. F) Frequency of cell cycle defects in sumo and ubc9 mutant GLC embryos.
doi:10.1371/journal.pone.0005905.g004
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wing discs were stained with an antibody against phosphohistone
H3 (pHH3) to mark the mitotic cells (Figure 6D–E9). sumo RNAi
resulted in a marked reduction of pHH3 positive cells throughout
the wing pouch (Figure 6E, E9, F). The proliferation defect was
especially pronounced in the dorsal compartment where the Gal4
driver is most active (Figure 6E, E9), and was also manifested in
adult wings, which were greatly reduced in size and misshapen
(Figure 6G). A similar requirement for SUMO in cell proliferation
was also observed in eye discs when ey-Gal4 was used to drive the
expression of sumo hairpin RNA (data not shown). Thus, SUMO is
required for both the atypical mitotic cycle that occurs in nuclear
cleavage stage embryos as well as the canonical cell cycles that
occur in cultured cells and larval imaginal discs.
Dynamic localization of SUMO during mitosis
Our immunofluorescence studies on sumo GLC embryos clearly
indicate that SUMO plays diverse roles at various stages of the
mitotic cycle. To gain further insight into the role of SUMO in the
cell cycle, we systematically documented the localization of
SUMO through stages of the nuclear cleavage cycle (Figures 7A,
C). Previous studies have shown that SUMO assumes a
predominantly nuclear distribution in the early embryo at
interphase [16]. This observation was confirmed in this study.
During interphase and prophase, SUMO is distributed throughout
the nucleus, but is concentrated in puncta of unknown structure
(Figure 7A). As the embryonic nuclei progress to metaphase,
SUMO associates with the condensing chromosomes and appears
to be concentrated in regions around the centromeres, as marked
by the points of closest association between the spindle and the
chromosomes (Figure 7C, left panels). This pericentromeric
localization is also consistent with the central ring of anti-SUMO
staining observed in the polar body chromosomes (Figure 7B), and
with previous observations of SUMO association with the
chromocenter of the polytene chromosome [16,22].
The association of SUMO with the pericentromeric regions of
the chromosomes persists during anaphase and telophase
(Figure 7C, center and right panels). In addition, SUMO also
localizes to the spindle midbodies, which are clearly framed by the
midzone spindles (the spindles between the segregating sister
chromatids), as they form during anaphase (Figure 7C, center
panels). Localization of SUMO to the midbody is even more
apparent during telophase (Figure 7C, right panels). The
association of SUMO with the chromosomes and midbody was
also observed in S2 cells (Figure 7E and data not shown). The
association of SUMO with the chromosomes throughout mitosis
and its localization to the midbodies during anaphase and
telophase is consistent with our observation that SUMO plays
Figure 5. Defects in the coordination of centrosome replication and spindle attachment in sumo GLC embryos. A–B) Syncytial
blastoderm Ore-R embryos. C) Uncoupled chromosome and centrosome replication observed in sumo
04493 GLC embryos. D–J) In sumo
04493 GLC
embryos, multiple defects in metaphase spindle morphology are observed, including examples of anastral (arrow in F), monoastral (H), multipolar (E,
G, arrows), as well as unfocused mitotic spindles (D9 and arrows in I, J). The embryos were stained for DAPI (blue), centrosomin (CNN, green), and a-
Tubulin (red).
doi:10.1371/journal.pone.0005905.g005
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PLoS ONE | www.plosone.org 10 June 2009 | Volume 4 | Issue 6 | e5905Figure 6. SUMO is required for cell cycle progression in cultured Drosophila cells and in larval tissues. A) FACS analysis of DNA content
in S2 cells treated with dsRNA against SUMO or YFP for 3, 4, or 5 days. The overall distribution (unfilled curve) has been fit to show the G1 (2N) and
G2/M (4N) cells (red-filled curves), the S phase cells (hatched curve), cells with less than 2N DNA content (blue-filled curves), and cells with more than
4N DNA content (green-filled curves). B) The percentages of YFP or SUMO dsRNA treated cells in G1, S, and G2/M phases. C–G) SUMO is required
for mitosis in wing imaginal discs. C) This MS1096.laminGFP wing disc shows the domain of MS1096-Gal4 expression. Mitotic cells were marked
by pHH3 staining in MS1096 (D),o rMS1096.sumoRNAi (E) third instar larval wing discs (all discs are oriented with dorsal on the top and anterior on
the right). C9, D9, and E9 show DAPI overlay of the images on the left. F) The numbers of pHH3 positive cells in multiple discs were counted and
averaged (standard errors are indicated). G) Adult wings from the MS1096 (left) or MS1096.sumoRNAi (right) flies.
doi:10.1371/journal.pone.0005905.g006
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PLoS ONE | www.plosone.org 11 June 2009 | Volume 4 | Issue 6 | e5905Figure 7. SUMO localization throughout the mitotic cycle. A) Interphase nuclei of syncytial blastoderm stage Oregon-R embryo stained with
SUMO antibodies (green) and DAPI (blue). B) Polar body stained with SUMO antibodies (green) and DAPI (blue) showing SUMO localization to the
pericentromeric regions of the polar body chromosomes. C) Metaphase, anaphase, and telophase nuclei of syncytial blastoderm embryo stained with
SUMO antibodies (green), a-tubulin antibodies (red), and DAPI (blue). Top panels show the SUMO/DAPI merge, while bottom panels show the SUMO/
a-tubulin merge. White arrowheads in left panels point to pericentromeric SUMO in one of the nuclei. Gray arrows in the center and right panels
point to spindle midzone SUMO. D) HA-Ubc9-expressing S2 cells [23] arrested at prometaphase with 25 mM colchicine and stained with SUMO
antibodies (red), HA antibodies (green, revealing localization of HA-Ubc9), and DAPI (blue). Ubc9 is diffusely localized but also exhibits intense puncta
that colocalize with SUMO near the kinetochores. E) S2 cell arrested at prometaphase with colchicine and stained with DAPI (blue), and antibodies
against SUMO (red) and Polo (green). SUMO and Polo partially colocalize at the outer kinetochore regions (white arrows point to the kinetochores of
one pair of sister chromatids). F) Syncyticial embryo expressing Polo-GFP (green; Polo-GFP flies were obtained from Dr. Claudio Sunkel) was stained
with DAPI (blue) and antibodies against SUMO (red). Polo and SUMO colocalize to the midbody (indicated for one nucleus by the gray arrow).
doi:10.1371/journal.pone.0005905.g007
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findings are also consistent with a report that SUMO-2/3 in HeLa
cells associates with the mitotic chromosome, while SUMO-1
associates with the spindle midzone [64]. Apparently, the multiple
mitotic functions of SUMO carried out by the single SUMO
isoform in Drosophila have been divided among multiple SUMO
isoforms in vertebrates.
The localization of SUMO during mitosis can be observed in
more detail in cultured cells. Cells arrested at prometaphase by
colchicine treatment display SUMO localization on condensed
chromosomes at the outer kinetochore and inner centromeric
regions (ICR) (Figure 7E). Like SUMO, Ubc9 assumes a
predominantly nuclear distribution during interphase (data not
shown). During mitosis, Ubc9 staining exhibited a largely diffuse
distribution along with concentrated foci that overlapped the
domain of SUMO localization at the centromeric regions and
kinetochores, suggesting that active sumoylation is taking place at
those locations (Figure 7D).
Polo, one ofthe SUMO targetsidentified in ourproteomic screen
and validated using the bacterial sumoylation system (Table 2,
Figure S4C), is the only Drosophila Polo-like kinase family protein.
Poloisinvolvedinmultiplestagesofcellcycleregulation,localizesto
the outer kinetochore early in mitosis, and subsequently relocalizes
to the midbodies late in mitosis [65]. Given these similarities
between the functions of SUMO and Polo, we decided to compare
directly the localization of SUMO and Polo during the mitotic
cycle. During interphase, Polo and SUMO occupy distinct cellular
compartments, being cytoplasmic and nuclear, respectively (data
not shown). During prometaphase and metaphase, partial overlap
between SUMO and Polo is observed at the outer kinetochore
(Figure 7E, and data not shown). At later stages of mitosis (anaphase
and later), Polo is localized to the midbody, and again exhibits
incomplete overlap with SUMO (Figure 7F). This partial co-
localization during multiple phases of mitosis suggests that Polo
could be one ofthe SUMO substratesat the kinetochores.However,
it also indicates that there are likely additional SUMO substrates at
the kinetochores and inner centromeric region, and that not all
kinetochore-associated Polo is sumoylated.
Discussion
The SUMO conjugation pathway is highly conserved in
eukaryotic evolution, and plays many key regulatory roles.
Drosophila embryos contain high levels of maternally supplied
SUMO, indicating that sumoylation may be especially important
in early Drosophila embryogenesis. Accordingly, reduced maternal
expression of SUMO has pleiotropic effects in oogenesis and
embryogenesis. Our proteomic, genetic, and cell culture analyses
converge to support roles for protein sumoylation in Ras signaling,
mitotic progression, and embryonic pattern formation.
SUMO and Ras signaling
The Ras signaling cascade is activated by a variety of RTKs
including EGFR, and controls cell proliferation and differentiation
as well as a large number of developmental patterning processes,
such as patterning of the eggshell [66–68]. Activation of EGFR in
the dorsal follicle cells during oogenesis leads to the sequential
activation of Ras, Raf, MEK, and MAPK, and results in the
upregulation of RTK target genes [69]. Complex positive and
inhibitory feedback loops ultimately result in the specification of
the dorsal follicle cells, which later secrete the dorsal eggshell,
including the dorsal appendages [52,70].
Previous genetic screens for mutations that enhance the eggshell
ventralization phenotype of a weak hypomorphic Ras1 allele
suggested a role for SUMO in the Ras pathway downstream of
EGFR activation [53]. In our analysis of the recessive sumo mutant
phenotype, we observed fused or single dorsal appendages,
indicative of eggshell ventralization and consistent with the
attenuation of EGFR signaling. Since the eggs under study
resulted from sumo GLCs, the observed eggshell defect could reflect
a function for SUMO upstream of EGFR in the production or
secretion by the germ line of EGFR ligands. However, since sumo
mutant clones are also present in the follicle cells of the GLC egg
chambers, the eggshell ventralization phenotype we observe is also
consistent with a role for SUMO downstream of EGFR activation
in the follicle cells. Interestingly, sumoylation pathway proteins in
C. elegans were also shown to interact with the Ras signaling
pathway [71]. Our cell culture experiments support a role for
protein sumoylation in Ras signaling that is downstream of EGFR
and upstream of, or parallel to, Ras activation. SUMO may
directly modulate Ras1 function since Ras1 was found in our
proteomic analysis and confirmed as a sumoylation substrate in
our bacterial sumoylation assay.
SUMO and cell cycle progression
Sumoylation is implicated in cell cycle regulation in many
organisms [59]. In this study, we observed diverse nuclear cleavage
defects in sumo GLC embryos suggestive of multiple roles for
SUMO in coordinating the chromosome cycle. The phenotypes,
including chromosome hypercondensation, aberrant segregation,
and polyploidy, are reminiscent of the defects observed in Ubc9-
deficient mouse embryos and Drosophila embryos mutant for pias,a
possible SUMO ligase [13,72], indicating conservation of SUMO
cell cycle functions in metazoan evolution. We also demonstrated
a requirement for SUMO in cell cycle progression in cultured cells
and in larval imaginal discs by RNAi-mediated SUMO knock-
down. While the cell proliferation defect in SUMO mutant wing
discs could result from a requirement for SUMO for the function
of many of the same cell cycle proteins found in our proteomic
screen of early embryos, it could also reflect a role for SUMO in
the function of Vg, a previously identified wing disc sumoylation
target [19] known to be required for wing growth [73–75].
In agreement with the diverse cell cycle defects in sumo mutant
embryos and other tissues, a spectrum of cell cycle regulators
involved in multiple stages of the cell cycle were identified in our
SUMO proteomic screens (Table 2). For example, the failure of
cultured cells to progress to G2/M could reflect a role for SUMO
in DNA replication, which is consistent with our finding that
PCNA, RFC2, Topoisomerase I, and Topoisomerase II are all
targets of sumoylation (Table 2 and Figure 1C). A role for SUMO
in the function of Polo kinase could further explain some of the
observed cell cycle defects since Polo has multiple roles in the cell
cycle [65,76]. Other sumoylation targets identified in our screen,
including PP2A, Arp3, Cofilin (Twinstar), Mago Nashi, and
Profilin, are also consistent with multiple roles of SUMO in
mitosis.
The requirement for SUMO throughout mitosis is further
supported by its dynamic, mitotic stage-dependent, localization. At
prometaphase and metaphase, sumoylated proteins are concen-
trated at the kinetochores and ICR, partially co-localizing with
Polo. Ubc9 co-localized with SUMO at the kinetochore-
centromeric regions during mitosis, suggesting that active
sumoylation is taking place at those locations. It is likely that
many kinetochore and centromere localized proteins are targeted
by SUMO, and cycles of sumoylation and de-sumoylation may
help to propel unidirectional mitotic progression.
While a number of studies have connected sumoylation to
centromere and kinetochore functions [59], spindle midbody
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midbody is a structure derived from the spindle midzone that
contains proteins indispensable for cytokinesis [78]. SUMO
association with the midbody, which we have observed in both
syncytial embryos and cultured cells beginning with anaphase and
extending through cytokinesis, therefore argues for a role of
sumoylation in the completion of cell division. The midbody
proteome has been dissected recently in mammalian cells,
revealing a large collection of proteins, including membrane
associated proteins, microtubule associated proteins, and kinases
[78]. Homologs of a number of these proteins, such as Arp3,
Cofilin (Twinstar), Mago Nashi, Polo, PP2A, and Profilin, were all
identified in our Drosophila SUMO proteomic screens (Table 2),
reinforcing the notion that SUMO is involved in midbody
function.
Cytokinesis does not occur in nuclear cleavage stage embryos.
However, the midbody has an important role in maintaining the
separation of telophase sister nuclei [79], a process that could be
related to the formation of pseudocleavage furrows at the end of
each nuclear cleavage cycle. Disruption of midbody function in
SUMO deficient embryos may therefore account for some of the
mitotic defects we observe in the syncytial embryo, including
polyploidy.
SUMO and embryonic patterning
We observe diverse patterning defects among the sumo GLC
embryos that developed a cuticle. In accordance with this
observation, three absolutely critical patterning proteins, Dorsal,
Bicoid, and Hunchback, are among the sumoylated proteins we
detected in early embryo extracts (Table 2). Previous studies have
shown that sumoylation of Dorsal potentiates its activity during the
immune response perhaps by making it a more potent transcrip-
tional activator [18]. While an earlier study showed that the loss of
Ubc9 results in a hunchback-like anterior patterning phenotype and
defective nuclear transport of Bicoid [12], our study is the first to
show that Hunchback, and its activator Bicoid, are direct SUMO
conjugation targets. Thus, it is possible that sumoylation of these
transcription factors plays a direct role in anterior patterning.
Posterior patterning and germ line specification depend upon
the posterior localization of the oskar transcript. We identified
several oskar mRNP components, including Mago Nashi, Tsunagi,
Cup, Hrb27C, and Smaug, as sumoylation targets (Table 2 and 3),
which have essential roles in the regulation of oskar mRNA
localization and translation [80]. This interesting and novel
finding suggests a role of SUMO in regulating the functions of
maternal mRNA by modifying components of oskar mRNP, and
therefore could explain some of the pleiotropic defects observed in
the embryonic patterning of embryos resulting from sumo mutant
GLCs.
The oskar mRNP is one of several instances in which multiple
members of the same complex appear to be direct targets of
sumoylation. For example, our screen turned up several members
of the multi-aminoacyl-tRNA synthetase complex, as well as
multiple ribosomal proteins (Table 3). Screens for sumoylation
targets in S. cerevisiae have similarly detected multiple sumoylation
targets in the same complex [26,29]. This suggests that oligomeric
protein complexes can be targeted as a whole for sumoylation
and/or that sumoylation may have a general role in stabilizing
protein complexes.
In contrast to previous studies in yeast and mammalian cell
culture [26,28,29,32–35], relatively few transcription factors were
identified in our study. This difference in fact accurately reflects
the unique metabolic state of the pre-cellularization embryo.
During the first two hours of Drosophila embryonic development,
rapid nuclear divisions depend upon a complex dowry of
maternally supplied proteins, as transcription of the zygotic
genome has not yet begun. Instead, the proper localization and
accurately regulated translation of maternally supplied mRNAs is
essential for establishing the system of positional information that
will later direct the spatially regulated transcription of the zygotic
genome [81]. Thus, the relatively small and selective group of
sumoylated transcription factors, along with the large number of
factors that control mRNA translation and localization found in
our screen, is consistent with regulatory roles for SUMO in this
critically important stage of fly development.
In conclusion, our genetic, cellular, and proteomic studies of
sumoylation suggest mechanisms for known biological roles of the
SUMO pathway and also uncover novel connections between
sumoylation, signal transduction, the cell cycle, and development.
Furthermore, our SUMO conjugated proteome should serve as a
rich resource for those studying the roles of sumoylation in
metazoan development.
Materials and Methods
Plasmid construction
Sequences encoding the (His)6- and FLAG-tags
(HHHHHHDYKDDDDK) were added to the 59 end of the sumo
coding region by PCR, using primers containing the sequences
corresponding to those tags as well as NotI and XbaI restriction sites
(primer sequences are given in supporting document S1). The
resulting PCR product was digested and ligated into the pUASp
vector [82] to produce pUASp-H6Flag-SUMO.
To construct the plasmid termed ‘‘Quartet’’ or ‘‘Q’’, which
expresses the Drosophila SUMO pathway in a single vector,
components of the pathway were first cloned into two Duet vectors
(Novagen), then combined into a single vector. Briefly, the mature
form of SUMO, SUMO
GG (last 2 amino acids omitted), and ubc9
were amplified from cDNAs by PCR, and cloned into pRSF-Duet-
1 MCS1 at the EcoRI/NotI sites, and MCS2 at the NdeI/XhoI sites,
respectively, to generate pRSF-SUMO
GG-Ubc9. Similarly, sae2
and sae1 were cloned into the MCS1 and MCS2 of the pCDF-
Duet-1 to create pCDF-SAE2-SAE1. Subsequently, the pCDF-
SAE2-SAE1 was digested with PfoI, filled in with Klenow, and
then cut at the AgeI site, and the sae2-sae1 fragment was then
introduced by ligation into the pRSF-SUMO-Ubc9 vector, which
has been digested with Bsu36I, blunted using Klenow, and then
digested with AgeI, to obtain, Q
SUMO (pRSF-SUMO
GG-Ubc9-
SAE2-SAE1). The control vector, Q
DGG (pRSF-SUMO
DGG-
Ubc9-SAE2-SAE1), which expresses a conjugation defective form
of SUMO, SUMO
DGG, in place of SUMO
GG, was constructed
using the same strategy. The ORFs of sumo and sae2 were cloned in
frame with an N-terminal (His)6 tag, and ubc9 and sae1 were cloned
in frame with a C-terminal S-tag.
The pGEX-loxP plasmid was generated by inserting a sequence
containing the loxP recombination site and bacterial promoter, for
Cre recombination and an antibiotic selection gene, respectively
(sequence information is available in The Creator Cloning System
Manual, Clontech), into pGEX-4T-1 (Amersham) at the EcoRI
and XhoI sites. This vector serves as an acceptor vector for
generating an in-frame amino terminal GST fusion with open
reading frames (ORFs) that have been introduced into a donor
vector. The donor pDNR-Dual vectors for PCNA (BS06345), RfC2
(BS06321), CtBP (BS10020), HP1 (BS03857), and Ras1 (BS04665)
were purchased from the Drosophila Genomics Resource Center
(DGRC). The ORFs of 14-3-3f, squid, polo, and eIF4E were
amplified from cDNA clones (RH61958, LD29474, BO04660,
and RE36735 from the DGRC) by PCR, and introduced into
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In-Fusion PCR Cloning Kit (Clontech). The ORFs were then
transferred from the pDNR vectors into the acceptor, pGEX-loxP
vector, by Cre recombination (Clontech). The eIF4E and Ras1
ORFs were also recombined into the S2 cell expression acceptor
vector, pMK33FlagHis-BD (obtained from Dr. Mark Stapleton).
The Ras
K104R point mutation was generated by PCR-based
site-directed mutagenesis of pDNR-Dual-Ras1. The Ras
1–164,
Ras
7KR, and Ras
165–189 were cloned into pDNR-Dual vector by
insertion of PCR products (see supporting document S1 for primer
sequences). The sequences encoding these Ras variants were then
recombined into the pGEX-loxP vector. The Ras
V12 point
mutation was created by PCR-based mutagenesis of the
pMK33FlagHis-Ras1 vector. All plasmids generated in this study
were sequenced to verify the presence of the correct inserts and
sequences (UCLA Genotyping and Sequencing Core).
Two-step purification of SUMO conjugates
Wild type Oregon-R embryos or embryos expressing tagged
SUMO, were collected at 25uC over a three-hour period, washed,
incubated at 37uC for an additional 45 minutes, then immediately
frozen under liquid nitrogen. Five grams of frozen embryos were
ground to power under liquid nitrogen and suspended in 20 ml of
Urea Binding buffer A (100 mM NaH2PO4, 10 mM Tris, pH 8.0,
8 M urea, 5 mM imidazole, and 1% CHAPS), which was freshly
supplemented with 40 mM N-ethylmaleimide (NEM, Sigma) and
one Mini Complete Protease Inhibitor Cocktail Tablet (Roche).
The suspension was further lysed witha FrenchPress, and the lysate
was centrifuged at 32,0006ga t4 uC for 20 min. The supernatant
wasfiltered usingMiracloth(CBC)toremovelipidclumps,andthen
mixed with1 ml of buffer A equilibrated Ni-NTA beads (QIAGEN)
at 22uC for one hour and 30 min in an Econo-column (BioRad).
After removal of the unbound material by gravity flow, the Ni-NTA
beads were washed twice with total of 40 ml of Wash buffer B
(100 mM NaH2PO4, 10 mM Tris, pH 8.0, 8 M urea, 5 mM
imidazole, and 1 mM PMSF), and eluted 4 times with 1 ml of
Elution buffer C (100 mM NaH2PO4, 10 mM Tris, pH 8.0, 8 M
urea, 20 mM EDTA, and 400 mM imidazole).
The eluted proteins were immediately dialyzed against three
liters of TBS (50 mM Tris, pH 7.4, 300 mM NaCl, 1 mM EDTA,
and 5% glycerol) over 2 hours at 4uC. The dialyzed sample was
further diluted five-fold with cold TBST buffer (TBS plus 1%
Triton X-100, and supplemented with 20 mM NEM and protease
inhibitor cocktail), and incubated with 100 ml of anti-FLAG
agarose (Sigma) at 4uC overnight. The next day, the beads were
separated from unbound proteins by centrifugation, washed four
times with TBST, and transferred to a spin collection column
(Zymo) to remove TBST. The proteins were eluted from the beads
with NuPAGE LDS loading buffer (Invitrogen) at 70uC for
15 min, and a portion of the eluted proteins were later separated
by SDS-PAGE and analyzed by Western blot or in-gel trypsin
digest followed by LC-MS/MS analysis of the tryptic peptides.
Protein identification by LC-MS/MS
The sliced SDS-PAGE gels were digested with sequencing-
grade trypsin (Promega). The digested peptides were extracted
from the gel slices using 50% acetonitrile/0.1% trifluoroacetic acid
(TFA) in water. The extracts were dried down, resuspended in
0.1% formic acid/water, and LC-MS/MS of the peptide mixtures
was performed on an Applied Biosystems QSTAR XL (ESI-
QqTOF) mass spectrometer coupled with an LC Packings
nanoflow HPLC system, through a nanoelectrospray ionization
source (Protana). A homemade trap column (150 mm62 mm) and
nano-column (75 mm6150 mm) packed with Jupiter Proteo C12
resin (particle size 4 mm, Phenomenex) were employed for the
nano-flow HPLC peptide separation using an 80-minute gradient.
Product ion (MS/MS) spectra of the peptides separated by HPLC
were recorded and then submitted to the Mascot database search
engine (Matrix Science) for protein identification. Positive protein
identification was based on standard Mascot scoring criteria
(p,0.05) for statistical analysis of the LC-MS/MS data. The
peptide assignments in the Mascot database search results were
then manually inspected for validation.
The bacterial sumoylation assay
A vector encoding a candidate SUMO conjugation target fused
to GST was co-transformed into BL21 cells (Novagen) with either
the Q
SUMO or the control Q
DGG expression vectors. Several
transformed bacterial colonies, selected for kanamycin and
ampicillin resistance, were picked to inoculate 0.5 ml cultures of
non-inducing medium, and shaken at 37uC overnight. This culture
was then used to inoculate 0.5 ml culture in auto-inducing
medium overnight at 25uC to induce expression of all five proteins.
The auto-induction was carried out as described by F. William
Studier [83]. These small-scale cultures were compared for levels
of expression of the GST fusion protein by anti-GST Western blot.
The culture with the highest expression was then scaled up to a
50 mL culture. The bacteria grown to saturation (O.D.600 of 12–
18) were collected by centrifugation, and the GST-fusion protein
was purified with glutathione beads according to the manufactur-
er’s protocol (Amersham). The eluted proteins were subsequently
resolved by SDS-PAGE, and analyzed by Sypro Ruby protein
staining and immunoblotting.
Fly stains and crosses
Flies were maintained on standard medium at 25uC. The
pUASp-H6Flag-SUMO vector was introduced into w
1118 flies by
embryo injection (Model System Genomics of Duke University).
Multiple lines with insertions into the X, second, or third
chromosomes were recovered. The MatGal4 driver, which encodes
Gal4-VP16 under the control of a maternally active a4-Tubulin
promoter was generously provided by Dr. Daniel St. Johnston.
The sumo mutant fly stocks used in this study are P[ry
[+t7.2]=PZ],
smt3
04493/CyO; ry
506 (referred to as sumo
04493 in this study; obtained
from Bloomington Stock Center) and Df
1w
67c23,y
1;
P[lacW]smt3
k01211/CyO (referred to as sumo
k01211; obtained from
Dr. Jon Schnorr). The original CyO balancer of the sumo mutant
lines was replaced with a GFP expressing CyO balancer (CyO,
ActGFP) to allow homozygous SUMO mutant flies (which lack
GFP) to be distinguished from their heterozygous siblings. The fly
strain containing a second chromosome insertion that expresses a
hairpin RNA against the SUMO gene under UAS control (UAS-
sumoRNAi) was obtained from the Vienna Drosophila RNAi Center.
Since the UAS-sumoRNAi flies are homozygous sterile, we balanced
the line with CyO, ActGFP to allow the UAS-sumoRNAi carrying flies
to be distinguished.
An FRT site (FRT40A) was introduced by recombination onto
the chromosome arms carrying the mutant sumo alleles. The
FRT40A line of mutant ubc9, semi
118, was a obtained from Dr.
Sochi Tanda [12]. The standard dominant female sterile FLP/
FRT protocols were followed to generate germ line clones of sumo
P-element alleles or semi
118 [49].
Scanning electron microscopy and cuticle preparation of
embryos
Fly embryos were attached to metal mounts as uncoated
samples using fingernail polish. Images were digitally acquired
SUMO in Drosophila Development
PLoS ONE | www.plosone.org 15 June 2009 | Volume 4 | Issue 6 | e5905using a Hitachi S-2460N Scanning Electron Microscope at a ‘high
pressure’ setting of 30 Pa using a Robinson detector. To prepare
embryo cuticles, dechorionated and devitellinized embryos were
mounted on slides in Hoyer’s mounting medium [84], and imaged
with dark field optics on a Zeiss Axioskop microscope.
Immunofluorescence and Western blotting
Primary antibodies used for immunofluorescence were rabbit
anti-SUMO [23], mouse anti-a-tubulin (Sigma), rabbit anti-CNN
[85], rabbit anti-pHH3 (pSer10, Sigma), mouse anti-Polo (a gift of
Dr. Claudio Sunkel), and mouse anti-HA (Sigma). Secondary
antibodies used were goat anti-rabbit or goat anti-mouse
antibodies conjugated with Alexa Fluor 488 or Alexa Fluor 568
(Molecular Probes). DNA was stained with 1 mg/ml 49,6-
diamidino-2-phenylindole (DAPI). Confocal images of the embry-
os and imaginal discs were obtained on a Leica one-photon
confocal laser scanning microscope (Leica Microsystems, Heidel-
berg). The S2 cells were visualized on a Deltavision Spectris
deconvolution microscopy system (Applied Precision), and the
images were deconvolved using Applied Precision software.
Antibodies used for immunoblotting were rabbit anti-ERK
(Sigma), mouse anti-dpERK (Sigma), rabbit anti-MEK (Cell
Signaling), rabbit anti-pMEK (Cell Signaling), mouse anti-FLAG
(Sigma), rabbit anti-SUMO [23], rabbit anti-GST (Abcam), and
mouse anti-poly-His (Sigma). Signal detection was achieved with
secondary antibody conjugated with horseradish peroxidase (HRP)
(CalBiochem) and SuperSignal West Pico substrates (Pierce).
Cell culture, RNA interference, and cell cycle analysis
Drosophila cultured cells were maintained at 24uC in Schneider’s
insect medium (Gibco) supplemented with 10% fetal bovine serum
(JHR) and antibiotics (Invitrogen). PCR products with T7
promoters on both ends (primer information is given in supporting
document S1) were used as templates for in vitro transcription to
make dsRNAs using the Megascript RNAi kit (Ambion). The
dsRNA was introduced into the cultured cells as described [86].
To establish stable cell lines expressing FLAG-(His)6-Ras
V12 or
FLAG-(His)6-eIF4E under inducible condition, the pMK33Fla-
gHis-Ras
V12 or pMK33FlagHis-eIF4E plasmid was transfected
into S2 cells using Effectene (QIAGEN). The transfected cells were
then selected with hygromycin until stable cell lines were
established. For the flow cytometry, cells were suspended in
Propidium Iodide DNA staining buffer [87], and analyzed on a
Becton Dickinson FACScan Analytic Flow Cytometer at the
UCLA Flow Cytometry Core Facility.
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